title: Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls.
abstract: OBJECTIVE
  Vitamin D receptor (VDR) gene plays an important role in bone mass regulation. We have previously shown a beneficial effect of vitamin D supplementation on bone mass in girls. This study investigated whether the musculo-skeletal response to Vitamin D was modulated by polymorphisms in VDR gene.
  
  
  METHODS
  Randomized placebo-controlled trial.
  
  
  METHODS
  179 girls (10-17 years), were randomly assigned to placebo or Vitamin D3 for one year. VDR genotypes were determined in 167 girls using BsmI, TaqI and ApaI restriction enzymes. Bone mass at the spine, hip, forearm and total body, and lean mass were measured by DXA at baseline and at one year.
  
  
  RESULTS
  After one year, VDR gene polymorphisms using Bsm1 and TaqI restriction enzymes were associated with percent changes in bone area, BMC and BMD at multiple skeletal sites in the Vitamin D3 group but not in the placebo group. The least increments were observed in the BB and tt genotypes. No similar effect was observed with ApaI enzyme. This relationship between VDR genotypes and changes in BMD and BMC remained significant after adjustment for puberty, changes in lean mass, height and bone area.
  
  
  CONCLUSIONS
  VDR gene polymorphisms influence the skeletal response to vitamin D supplementation in healthy adolescent girls.
authors: Calcium Metabolism and Osteoporosis Program, American University of Beirut, Beirut, Lebanon. aa22@aub.edu.lb
authors: Asma
authors: A
authors: Arabi
authors: Laila
authors: L
authors: Zahed
authors: Ziyad
authors: Z
authors: Mahfoud
authors: Lina
authors: L
authors: El-Onsi
authors: Mona
authors: M
authors: Nabulsi
authors: Joyce
authors: J
authors: Maalouf
authors: Ghada El-Hajj
authors: Gel-H
authors: Fuleihan
mesh_terms: D000293:Adolescent; D000886:Anthropometry; D015519:Bone Density / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000502:physiology*; D002648:Child; D002762:Cholecalciferol / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D005260:Female; D005838:Genotype; D006262:Health; D006801:Humans; D015999:Multivariate Analysis; D010919:Placebos; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000235:genetics*
chemical_list: D010919:Placebos; D018167:Receptors, Calcitriol; D002762:Cholecalciferol